Global X Genomics & Biotechnology ETF
GNOM
19 hedge funds and large institutions have $38.1M invested in Global X Genomics & Biotechnology ETF in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.
1,000% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 1
111% more funds holding
Funds holding: 9 → 19 (+10)
35% more capital invested
Capital invested by funds: $28.3M → $38.1M (+$9.78M)
1.57% less ownership
Funds ownership: 17.13% → 15.57% (-1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$3.59M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.64M |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$1.6M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$775K |
| 5 |
Jane Street
New York
|
+$620K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$559K |
GNOM Hedge Fund Activity: Q3 2020 in Review
19 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q3 2020, worth a combined $38.1M — up 35% from $28.3M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new GNOM positions and 1 closed out — a net gain of 10 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Mirae Asset Global Investments, opening a new position worth an estimated $3.59M. The largest seller was Citadel Advisors, exiting entirely with an estimated $559K sold.
- 19 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q3 2020, up from 9 in Q2 2020.
- Funds reported $38.1M of Global X Genomics & Biotechnology ETF stock for Q3 2020, up 35% quarter-over-quarter.
- 11 funds opened new Global X Genomics & Biotechnology ETF positions in Q3 2020 and 1 closed out, a net change of +10 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q3 2020 was Mirae Asset Global Investments, an estimated $3.59M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q3 2020 was Citadel Advisors, an estimated $559K sold.
Based on aggregated 13F filings for Q3 2020.